[{"PropertyPlantAndEquipmentNet_0_Q3_USD":41215000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_3_Q3_USD":1800000.0,"DepreciationAndAmortization_3_Q3_USD":5447000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"LiabilitiesNoncurrent_0_Q3_USD":141953000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":30746000.0,"InterestPaidNet_3_Q3_USD":4503000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":-17883000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-63834000.0,"StockIssuedDuringPeriodValueNewIssues_3_Q3_USD":29565000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_3_Q3_USD":-27790000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q3_USD":-13288000.0,"AssetsCurrent_0_Q3_USD":593764000.0,"OtherNoncashIncomeExpense_3_Q3_USD":2862000.0,"SellingGeneralAndAdministrativeExpense_3_Q3_USD":42323000.0,"SellingGeneralAndAdministrativeExpense_1_Q3_USD":12023000.0,"DerivativeGainLossOnDerivativeNet_3_Q3_USD":23242000.0,"ProceedsFromIssuanceOfLongTermDebt_3_Q3_USD":34603000.0,"CostOfGoodsAndServicesSold_3_Q3_USD":23178000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":3309299.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":4200111.0,"StockIssuedDuringPeriodValueStockOptionsExercised_3_Q3_USD":1824000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":914000.0,"CommonStockSharesIssued_0_Q3_shares":46207776.0,"Assets_0_Q3_USD":774625000.0,"ShareBasedCompensation_3_Q3_USD":18747000.0,"Liabilities_0_Q3_USD":183870000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":29733000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":578464000.0,"OtherAssetsNoncurrent_0_Q3_USD":5668000.0,"EarningsPerShareBasic_3_Q3_USD":7.0,"EarningsPerShareBasic_1_Q3_USD":-0.79,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_Q3_USD":-2589000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":46780963.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":46152404.0,"PrepaidExpenseCurrent_0_Q3_USD":10345000.0,"OtherExpenses_3_Q3_USD":673000.0,"OtherExpenses_1_Q3_USD":214000.0,"AccountsReceivableNetCurrent_0_Q3_USD":3771000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":3560000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":89000.0,"CommonStockValue_0_Q3_USD":2797000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":26194000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_3_Q3_USD":23200000.0,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q3_USD":10436000.0,"EffectiveIncomeTaxRateContinuingOperations_3_Q3_pure":-0.011,"EffectiveIncomeTaxRateContinuingOperations_1_Q3_pure":0.002,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":64964000.0,"CostsAndExpenses_3_Q3_USD":166710000.0,"CostsAndExpenses_1_Q3_USD":48455000.0,"PaymentsOfStockIssuanceCosts_3_Q3_USD":1334000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_3_Q3_USD":321381000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q3_USD":-36531000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":293591000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-49819000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":2003000.0,"ForeignCurrencyTransactionGainLossBeforeTax_3_Q3_USD":21645000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":36432000.0,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":1971000.0,"CommonStockParOrStatedValuePerShare_0_Q3_EUR":0.05,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q3_USD":-13288000.0,"Goodwill_0_Q3_USD":28060000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":324941000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":-36442000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3_Q3_USD":18747000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":5955000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":335049000.0,"RepaymentsOfDebt_3_Q3_USD":1175000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":45888769.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":46152404.0,"LiabilitiesCurrent_0_Q3_USD":41917000.0,"AccountsPayableCurrent_0_Q3_USD":5373000.0,"InterestExpense_3_Q3_USD":5377000.0,"InterestExpense_1_Q3_USD":1924000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":581270000.0,"LongTermDebtNoncurrent_0_Q3_USD":71490000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q3_USD":64005000.0,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_3_Q3_pure":0.25,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1_Q3_pure":0.25,"AdditionalPaidInCapital_0_Q3_USD":1069191000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_3_Q3_USD":146000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q3_USD":97000.0,"FiniteLivedIntangibleAssetsNet_0_Q3_USD":64005000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q3_USD":13141000.0,"BusinessCombinationContingentConsiderationLiabilityNoncurrent_0_Q3_USD":23781000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3_Q3_USD":-27790000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":35900000.0,"RestrictedCashNoncurrent_0_Q3_USD":2806000.0,"EarningsPerShareDiluted_1_Q3_USD":-0.79,"PaymentsToAcquireBusinessesNetOfCashAcquired_3_Q3_USD":49949000.0,"CommonStockSharesAuthorized_0_Q3_shares":80000000.0,"OperatingIncomeLoss_3_Q3_USD":308550000.0,"OperatingIncomeLoss_1_Q3_USD":-45000000.0,"ProceedsFromIssuanceInitialPublicOffering_3_Q3_USD":30899000.0,"InvestmentIncomeInterest_3_Q3_USD":123000.0,"InvestmentIncomeInterest_1_Q3_USD":46000.0,"DeferredIncomeTaxExpenseBenefit_3_Q3_USD":3560000.0,"DeferredIncomeTaxExpenseBenefit_1_Q3_USD":200000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":774625000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":10900000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":5798000.0,"DeferredIncomeTaxAssetsNet_0_Q3_USD":15719000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_3_Q3_USD":11592000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":3808000.0,"StockholdersEquity_0_Q3_USD":590755000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":13885000.0,"OtherIncome_3_Q3_USD":9622000.0,"OtherIncome_1_Q3_USD":1680000.0,"AssetsNoncurrent_0_Q3_USD":180861000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_3_Q3_USD":466311000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q3_USD":1989000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-463350000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":333590000.0,"CommonStockSharesOutstanding_0_Q3_shares":46207776.0,"EarningsPerShareDiluted_3_Q3_USD":6.87,"ProfitLoss_3_Q3_USD":321381000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":101209000.0,"Ticker":"QURE","CIK":"1590560","name":"UNIQURE N.V.","OfficialName":"uniQure N.V. Ordinary Shares","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"814390930.0","Country":"Netherlands","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211025"}]